查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1623353

動物保健市場規模（按地區、範圍和預測）

Veterinary Medicine Market Size By Product, By Animal Type, By Route of Administration, By Distribution Channel, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

動物藥品的市場規模及預測

2023 年動物保健市場規模價值為 467.4 億美元，預計到 2031 年將達到 850.5 億美元，2024 年至 2031 年的複合年增長率為 7.77%。獸醫學是研究動物健康和福利的醫學分支。診斷、治療、預防和管理各種動物（包括寵物、農場動物、野生動物和動物園動物）的疾病和傷害。獸醫學應用解剖學、生理學、病理學、藥理學和外科學等多個學科的思想和程序來解決動物獨特的健康課題。獸醫促進動物福利，透過控制人畜共患疾病（可在動物和人類之間傳播的疾病）保護公眾健康，並透過牲畜檢查和監管確保食品安全，並在為科學研究做出貢獻方面發揮著重要作用。

此外，獸醫學不僅限於臨床護理，還包括動物行為、營養、繁殖和流行病學，滿足單一動物和動物群體的整體健康需求。

全球獸藥市場動態

主要市場驅動因子

增加寵物飼養和人性化：

全球範圍內寵物擁有量的不斷增長，加上人們將寵物視為家庭成員的日益人性化，推動了獸藥的需求。這一趨勢將鼓勵更頻繁、更全面的寵物醫療保健和健康檢查，從而增加對獸醫產品和服務的需求。

動物醫學的進展：

動物診斷、藥物和疫苗技術的進步提高了獸醫護理的有效性和效率。遠距醫療、穿戴式健康監測器和先進的外科手術正在透過改善治療結果和增加可用的服務範圍來促進獸醫保健市場的發展，從而推動市場成長。

提高對動物健康與福利的認識：

寵物主人和農民越來越意識到動物健康和福利的重要性，從而對積極主動和預防性的醫療保健方法產生了需求。這種日益增強的認知推動了對疫苗接種、營養補充劑和定期健康檢查的需求，進一步促進了獸藥市場的發展。

擴大畜牧業生產與動物健康管理：

為了滿足全球對動物性蛋白質日益增長的需求，必須實施適當的健康管理措施，以確保動物福利和食品安全。對牲畜疾病有效預防和控制的需求刺激了對疫苗、抗菌藥物和殺蟲劑等獸藥的需求，從而促使市場不斷擴大。

主要問題

動物保健成本上升：

獸醫服務和藥品成本的上漲限制了寵物主人和牲畜生產者獲得治療的機會，尤其是在低收入地區。結果，高昂的醫療費用使人們不願意定期去看獸醫和預防性治療，損害了動物的健康和福利，並對市場造成了重大障礙。

抗菌素抗藥性（AMR）：

動物過度使用和濫用抗生素是抗菌藥物抗藥性日益嚴重的問題，對公共衛生構成重大風險。這項課題不僅導致了更嚴格的監管要求，還需要開發替代藥物，從而影響動物保健市場對傳染病的治療方式。

供應鏈漏洞：

動物保健市場容易受到供應鏈中斷的影響，進而影響關鍵藥物和疫苗的供應。原料限制、物流瓶頸和地緣政治緊張都會造成供應限制，限製成功滿足動物健康需求的能力並抑制市場擴張。

主要趨勢：

遠距醫療與數位健康平台：

遠距醫療和數位健康平台允許遠端諮詢和監控，在獸醫領域越來越受歡迎。該技術改善了人們獲得獸醫服務的機會，特別是在貧困地區，並透過使用應用程式和穿戴式裝置促進了動物的持續健康管理。

個人化與精準醫療：

人們越來越重視個人化獸醫學，它使用基因檢測和現代診斷方法根據每隻動物的特定需求制定治療方案。此策略可以改善治療結果，最大限度地減少副作用，並允許更精確的疾病管理策略。

可持續且合乎道德的做法：

道德考量和永續性日益影響著動物保健市場。人們開始轉向生產和消費生態友善且符合道德規範的產品。這一發展反映了消費者對動物照護程序透明度和責任感的更廣泛渴望。

擴大獸醫服務：

獸醫診所正在將其服務範圍擴展到傳統醫療保健之外，包括健康計劃、營養建議、行為療法和針灸等替代療法。人們越來越意識到寵物和農場動物身心健康的重要性，從而轉向全面的動物保健服務。

目錄

第 1 章 全球動物保健市場簡介

  • 市場定義
  • 市場區隔
  • 調查安排
  • 先決條件
  • 限制

第 2 章：經過驗證的市場研究方法

  • 資料探勘
  • 數據三角測量
  • 由下而上的方法
  • 自上而下的方法
  • 調查流程
  • 產業專家的重要見解
  • 資料來源

第 3 章執行摘要

    市場概況
  • 生態製圖
  • 絕對的獲利機會
  • 市場吸引力
  • 全球動物保健市場（按地區）分析
  • 全球動物藥品市場（依動物類型劃分）
  • 按產品類型劃分的全球動物保健產品市場
  • 未來市場機會
  • 全球市場細分
  • 產品生命線

第 4 章：動物保健產品全球市場展望

  • 世界各地動物藥物的演變
  • 驅動程式
  • 阻礙因素
  • 機會
  • 波特五力模型
  • 價值鏈分析
  • 價格分析
  • 宏觀經濟分析

5. 全球動物藥品市場（依動物類型）

  • 概述
  • 生產動物
  • 伴侶動物

6. 全球動物保健產品市場（依產品類型）

  • 概述
  • 藥品
  • 疫苗
  • 藥物飼料添加劑

第 7 章。
  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
    亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 其他中東和非洲地區

第 8 章。
  • 概述
  • 各公司的市場排名
  • 重大進展
  • 公司地理分佈
  • 公司產業足跡
  • ACE 矩陣

第九章 公司簡介

  • Zoetis Inc
  • Virbac SA
  • Soparfin SCA
  • Merck & Co Inc
  • Evonik Industries
  • Elanco Animal Health Incorporated
  • Dechra Pharmaceuticals PLC
  • Ceva Sante Animale
  • Boehringer Ingelheim International GmbH
  • Archer Daniels Midland

第 10 章 經過驗證的市場情報

    關於經過驗證的市場情報
  • 動態資料視覺化
簡介目錄
Product Code: 21894

Veterinary Medicine Market Size And Forecast

Veterinary Medicine Market size was valued at USD 46.74 Billion in 2023 and is projected to reach USD 85.05 Billion by 2031, growing at a CAGR of 7.77% from 2024 to 2031. Veterinary medicine is a branch of medical science that studies the health and well-being of animals. It entails the diagnosis, treatment, prevention, and management of diseases and injuries in a wide variety of animal species, such as pets, cattle, wildlife, and zoo animals. Veterinary medicine addresses animals' particular health challenges by applying ideas and procedures from several disciplines such as anatomy, physiology, pathology, pharmacology, and surgery. Veterinarians play an important role in promoting animal welfare, protecting public health by controlling zoonotic diseases (those that can spread between animals and humans), ensuring food safety through livestock inspection and regulation, and contributing to scientific research.

Additionally, veterinary medicine goes beyond clinical care to include animal behavior, nutrition, reproduction, and epidemiology, addressing the overall health needs of both individual animals and animal groups.

Global Veterinary Medicine Market Dynamics

The key market dynamics that are shaping the veterinary medicine market include:

Key Market Drivers

Rising Pet Ownership and Humanization:

The growing global trend of pet ownership, combined with the humanization of pets such that they are considered members of the family, boosts demand for veterinary medicine. This tendency encourages more frequent and comprehensive pet healthcare and wellness checkups, hence increasing demand for veterinarian products and services.

Advancements in Veterinary Healthcare:

Technological advances in animal diagnostics, medicines, and immunizations improve the effectiveness and efficiency of veterinary treatment. Telemedicine, wearable health monitors, and sophisticated surgical procedures help to develop the veterinary medical market by improving treatment outcomes and broadening the range of services available, fueling market growth.

Growing Awareness of Animal Health and Welfare:

Pet owners and farmers are becoming more conscious of the importance of animal health and welfare, which has led to proactive and preventive healthcare methods. This increased awareness is fueling demand for immunizations, nutritional supplements, and regular health screenings, boosting the veterinary medicine market even further.

Expansion of Livestock Production and Farm Animal Health Management:

To meet the expanding worldwide demand for animal protein, appropriate health management methods must be implemented to ensure animal welfare and food safety. The requirement for effective disease prevention and control in farm animals is fueling the demand for veterinary medicines such as vaccinations, antimicrobials, and parasiticides, resulting in market expansion.

Key Challenges:

Rising Costs of Veterinary Care:

The rising expense of veterinary services and medications restricts access to treatment for pet owners and livestock producers, particularly in regions with low incomes. Thus, high costs discourage regular veterinary visits and preventive treatments, compromising animal health and welfare, and posing a significant hurdle for the market.

Antimicrobial Resistance (AMR):

Overuse and misuse of antibiotics in animals contribute to the growing problem of AMR, which poses a substantial public health risk. This difficulty needs the development of alternate medicines as well as tight regulatory requirements, which will have an impact on the way the veterinary medicine market treats infectious diseases.

Supply Chain Vulnerabilities:

The veterinary medication market is vulnerable to supply chain disruptions, which impact the availability of critical medicines and vaccines. Raw material limitations, logistical obstacles, and geopolitical tensions all cause supply limits, limiting the ability to successfully meet the demand for veterinary care, and inhibiting market expansion.

Key Trends:

Telemedicine and Digital Health Platforms:

Telemedicine and digital health platforms are becoming increasingly popular in veterinary care, allowing for remote consultations and monitoring. This technology improves access to veterinary services, particularly in poor areas, and promotes continuing health management for animals using applications and wearable devices.

Personalized and Precision Medicine:

There is a rising emphasis on personalized veterinary medicine, which uses genetic testing and modern diagnostics to adapt therapies to the unique needs of each animal. This strategy enhances treatment outcomes, minimizes adverse effects, and allows for more accurate disease management tactics.

Sustainable and Ethical Practices:

Ethical considerations and sustainability are increasingly influencing the veterinary care market. There is a shift towards creating and consuming ecologically friendly and ethically sourced items. This development reflects a broader consumer desire for transparency and accountability in animal care procedures.

Expansion of Veterinary Services:

Veterinary practices are expanding their services beyond traditional treatment to include wellness programmes, nutritional advice, behavioural therapy, and alternative therapies such as acupuncture. This shift towards comprehensive animal healthcare services is being pushed by a growing realization of the importance of mental and physical well-being in pets and livestock.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Veterinary Medicine Market Regional Analysis

Here is a more detailed regional analysis of the veterinary medicine market:

North America:

According to Verified Market Research, North America is estimated to dominate the veterinary medicine market over the forecast period. North America, especially the United States, has one of the highest pet ownership rates in the world. This large pet population creates a high demand for veterinarian services and products like of wellness checkups, surgical treatments, and medications, bolstering the region's supremacy in the veterinary medicine market.

The region has a well-developed veterinary healthcare infrastructure, which includes cutting-edge veterinary hospitals, clinics, and research facilities. This enhanced infrastructure enables the delivery of cutting-edge therapies and breakthroughs in animal health care, hence contributing to the market's expansion and development.

Furthermore, North American consumers are highly aware of the importance of pet and animal health and are willing to invest accordingly. The cultural relevance of pets as family members results in large spending on preventative care, diagnostics, and treatments, boosting the region's veterinary medicine market growth.

Europe:

Europe is home to some of the world's best veterinary research facilities and pharmaceutical businesses, which have helped to develop veterinary care significantly. Continuous investment in R&D yields breakthrough medicines and diagnostic tools, moving the veterinary medicine market ahead.

The trend of pet humanization is especially prominent in Europe, where an increasing percentage of households' pets and treated like family members. This leads to increased spending on pet healthcare, such as preventive care, wellness products, and specialized treatments, driving market expansion.

Furthermore, the rising knowledge of zoonotic illnesses in Europe, particularly following occurrences such as the COVID-19 pandemic, is shifting the emphasis to animal health as a component of public health. This increased awareness regarding zoonotic disease immunizations, diagnostics, and treatments is propelling the veterinary medicine market.

Asia Pacific:

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The region's expanding population and rising wages have raised the demand for animal protein, resulting in a major expansion in the cattle business. This expansion needs improved animal health management methods, such as preventive care and immunizations, bolstering the veterinary medication market.

Government policies and consumer demand are driving an increase in awareness and concern for animal health and welfare throughout Asia Pacific. This increased attention encourages the adoption of better healthcare practices for both pets and cattle, contributing to market growth.

Furthermore, government and corporate sector investments in veterinary healthcare infrastructure, like as hospitals, clinics, and research centers, are increasing across the Asia-Pacific region. These expenditures provide access to veterinary services and encourage the adoption of innovative healthcare technology, hence moving the veterinary medicine market forward.

Global Veterinary Medicine Market: Segmentation Analysis

The Global Veterinary Medicine Market is Segmented on the basis of Product, Animal Type, Route of Administration, Distribution Channel, and Geography.

Veterinary Medicine Market, By Product

  • Drugs
  • Vaccines

Based on the Product, the market is segmented into Drugs and Vaccines. The vaccines segment is estimated to dominate the veterinary medicine market. Vaccines serve an important role in preventative veterinary care because they provide protection against a wide range of infections, lowering disease outbreaks, and the need for antibiotic treatments, and eventually leading to healthier animal populations. The increased focus on animal welfare, combined with rigorous legislation for immunization of pets and animals, spurring up demand for vaccinations.

Veterinary Medicine Market, By Animal Type

  • Domesticated
  • Companion

Based on the Animal Type segment, the market is segmented into Domesticated and Companion. The companion animal type segment is estimated to dominate the veterinary medicine market during the forecast period due to the growing tendency of pet humanization, in which pets are increasingly seen as full members of the family. As a result, pet owners are increasingly ready to invest in their pets' health and well-being, boosting demand for a diverse variety of veterinarian services and products such as preventive immunizations, diagnostics, medicines, and nutritional supplements. Furthermore, the rise in pet ownership rates, particularly in affluent countries, is stirring up the demand for companion animal veterinarian care.

Veterinary Medicine Market, By Route Of Administration

  • Oral
  • Parental

Based on the Route of Administration, the market is segmented into Oral and Parental. The parental segment is estimated to exhibit the highest growth within the veterinary medicine market. The parenteral route, which includes intravenous, intramuscular, and subcutaneous injections, is critical for delivering drugs directly into the bloodstream, resulting in a faster and more regulated response than oral routes. This is especially important in treating severe or acute illnesses that require quick absorption. Parenteral treatments have a considerable market share due to their dependability and efficacy in critical care circumstances, even though they require professional administration and can cause animals more stress than oral alternatives.

Veterinary Medicine Market, By Distribution Channel

  • Veterinary Hospitals & Clinics
  • Retail Stores
  • Online Pharmacies

Based on the Distribution Channel, the market is segmented into Veterinary Hospitals and Clinics, Retail Stores and Online Pharmacies. The veterinary hospitals & clinics segment is estimated to dominate the veterinary medicine market due to the comprehensive care and broad variety of services provided by these hospitals, which include diagnostic, treatment, surgery, and emergency care. Veterinary hospitals and clinics are the first point of contact for pet owners and livestock producers looking for expert, specialized treatment for their animals. They not only provide fast access to a wide range of veterinary pharmaceuticals, such as prescription drugs, vaccines, and treatments, but also the experience of veterinary professionals to ensure proper diagnosis and treatment regimens.

Veterinary Medicine Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, the veterinary medicine market is classified into North America, Europe, Asia Pacific, and the Rest of the world. According to the VMR analyst, North America is estimated to dominate during the forecasted period. This region has a strong and advanced veterinary healthcare infrastructure, which includes world-class veterinary hospitals, clinics, and research institutions that help deliver cutting-edge care and encourage veterinary medicine advances. Furthermore, strong regulatory standards maintain high-quality care and product safety, which strengthens consumer trust and market stability.

Key Players

  • The "Veterinary Medicine Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Zoetis, Merck & Co., Elanco, Boehringer Ingelheim, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Phibro Animal Health Corporation, Inventory Ally, Virbac, Bimeda Corporate, Chewy, Vetoquinol SA, Neogen Corporation, China Animal Husbandry Co., Sanofi SA, Loyal Companion, Bayer Animal Health, IDEXX Laboratories, Royal Canin SAS and Nestle Purina PetCare Company.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Veterinary Medicine Market Recent Developments
  • In February 2024, Chewy, an online pet retailer, announced plans to construct brick-and-mortar veterinarian clinics in Florida and Colorado, further increasing its influence in the pet healthcare market.
  • In February 2024, Loyal Companion, a pet health company, announced that they are looking for senior dogs to participate in a study that will assess the efficacy of a prospective canine longevity medicine.
  • In February 2024, Inventory Ally, a cloud-based software system, won the 2024 Pet Pitch Prize competition for its contribution to streamlining inventory management and purchasing in veterinary facilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VETERINARY MEDICINE MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Veterinary Medicine Market Geographical Analysis (CAGR %)
  • 3.6 Global Veterinary Medicine Market, By Animal Type (USD Million)
  • 3.7 Global Veterinary Medicine Market, By Product Type (USD Million)
  • 3.8 Future Market Opportunities
  • 3.9 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL VETERINARY MEDICINE MARKET OUTLOOK

  • 4.1 Global Veterinary Medicine Evolution
  • 4.2 Drivers
    • 4.2.1 Driver 1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint 1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity 1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE

  • 5.1 Overview
  • 5.2 Production Animals
  • 5.3 Companion Animals

6 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT TYPE

  • 6.1 Overview
  • 6.2 Drugs
  • 6.3 Vaccines
  • 6.4 Medicated Feed Additives

7 GLOBAL VETERINARY MEDICINE MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of Latin America
  • 7.6 Middle-East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL VETERINARY MEDICINE MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Developments
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Zoetis Inc
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Product Benchmarking
    • 9.1.4 Key Development
    • 9.1.5 Winning Imperatives
    • 9.1.6 Current Focus & Strategies
    • 9.1.7 Threat from Competition
    • 9.1.8 SWOT Analysis
  • 9.2 Virbac SA
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Product Benchmarking
    • 9.2.4 Key Development
    • 9.2.5 Winning Imperatives
    • 9.2.6 Current Focus & Strategies
    • 9.2.7 Threat from Competition
    • 9.2.8 SWOT Analysis
  • 9.3 Soparfin SCA
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Product Benchmarking
    • 9.3.4 Key Development
    • 9.3.5 Winning Imperatives
    • 9.3.6 Current Focus & Strategies
    • 9.3.7 Threat from Competition
    • 9.3.8 SWOT Analysis
  • 9.4 Merck & Co Inc
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Product Benchmarking
    • 9.4.4 Key Development
    • 9.4.5 Winning Imperatives
    • 9.4.6 Current Focus & Strategies
    • 9.4.7 Threat from Competition
    • 9.4.8 SWOT Analysis
  • 9.5 Evonik Industries
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Product Benchmarking
    • 9.5.4 Key Development
    • 9.5.5 Winning Imperatives
    • 9.5.6 Current Focus & Strategies
    • 9.5.7 Threat from Competition
    • 9.5.8 SWOT Analysis
  • 9.6 Elanco Animal Health Incorporated
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Product Benchmarking
    • 9.6.4 Key Development
    • 9.6.5 Winning Imperatives
    • 9.6.6 Current Focus & Strategies
    • 9.6.7 Threat from Competition
    • 9.6.8 SWOT Analysis
  • 9.7 Dechra Pharmaceuticals PLC
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Product Benchmarking
    • 9.7.4 Key Development
    • 9.7.5 Winning Imperatives
    • 9.7.6 Current Focus & Strategies
    • 9.7.7 Threat from Competition
    • 9.7.8 SWOT Analysis
  • 9.8 Ceva Sante Animale
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Product Benchmarking
    • 9.8.4 Key Development
    • 9.8.5 Winning Imperatives
    • 9.8.6 Current Focus & Strategies
    • 9.8.7 Threat from Competition
    • 9.8.8 SWOT Analysis
  • 9.9 Boehringer Ingelheim International GmbH
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Product Benchmarking
    • 9.9.4 Key Development
    • 9.9.5 Winning Imperatives
    • 9.9.6 Current Focus & Strategies
    • 9.9.7 Threat from Competition
    • 9.9.8 SWOT Analysis
  • 9.10 Archer Daniels Midland
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Product Benchmarking
    • 9.10.4 Key Development
    • 9.10.5 Winning Imperatives
    • 9.10.6 Current Focus & Strategies
    • 9.10.7 Threat from Competition
    • 9.10.8 SWOT Analysis

10 VERIFIED MARKET INTELLIGENCE

  • 10.1 About Verified Market Intelligence
  • 10.2 Dynamic Data Visualization